Reducing the incidence and severity of herpes zoster and PHN with zoster vaccination

J Am Osteopath Assoc. 2009 Jun;109(6 Suppl 2):S18-21.

Abstract

The results of the Shingles Prevention Study, a Cooperative Studies Program conducted through the US Department of Veterans Affairs, are summarized. Also provided are general recommendations and contraindications for the use of zoster vaccine live among patients aged 60 years or older.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Age Factors
  • Aged
  • Herpes Zoster / epidemiology*
  • Herpes Zoster / prevention & control*
  • Herpes Zoster Vaccine*
  • Humans
  • Incidence
  • Middle Aged

Substances

  • Herpes Zoster Vaccine